12 Oct 2023 --- Danish bioscience company Chr. Hansen reports revenue of €352 million (US$374 million) for Q4 2022/23, up 7% from €328 million (US$ million) in Q4 2021/22. The company notes that earnings growth was driven by volume growth, pricing initiatives and stable operating expenses, partly offset by the negative impact of higher input costs and exchange rates.
